PharmaSUG2023paper·China·4 Data Standards and Submission
Implementation and challenge of submission package translation from Chinese to English DS-174 Nanjing
Official-source directory
Conference Papers
13,885
available papers
10
available conferences
Papers
Showing 4021–4040 of 13,885
PharmaSUG2023paper·China·4 Data Standards and Submission
ISS between FDA, EMA & NMPA: Similarities vs. Differences & Programming Tips DS-177 Nanjing
PharmaSUG2023paper·China·4 Data Standards and Submission
Industry Metrics for Standards Utilization and Validation Rules DS-184 Nanjing
PharmaSUG2023paper·China·5 Data Visualization and Reporting
Application of R language in clinical data DV-105 Nanjing
PharmaSUG2023paper·China·5 Data Visualization and Reporting
Sunburst Plot Analysis and Submission to FDA with Python DV-124 Nanjing
PharmaSUG2023paper·China·5 Data Visualization and Reporting
How to Use Grid Package to Draw a Forest Plot DV-153 Nanjing
PharmaSUG2023paper·China·5 Data Visualization and Reporting
GTL or SGPLOT: Which one to choose? DV-163 Nanjing
PharmaSUG2023paper·China·5 Data Visualization and Reporting
Interactive Table Cross-Querying and Spotlight Effects in Shiny Apps with jQuery DV-171 Nanjing
PharmaSUG2023paper·China·5 Data Visualization and Reporting
Simplify the safety and effectiveness research of drug development process DV-192 Nanjing
PharmaSUG2023paper·China·6 Leadership Skills
Agile team organization in pharmaceutical data science - Why we should be moving lots of small rocks rather than the one big mountain LS-109 Nanjing
PharmaSUG2023paper·China·6 Leadership Skills
Traveling office: How does remote working change our life of work LS-162 Nanjing
PharmaSUG2023paper·China·6 Leadership Skills
The Relationship of Artificial Intelligence technology and Employees' employment, performance and career development: An interview based research in clinical programming area LS-167 Nanjing
PharmaSUG2023paper·China·6 Leadership Skills
Procedure Matrix: build the department assets of standardization LS-176 Nanjing
PharmaSUG2023paper·China·7 Statistics and Analytics
Programming Approaching for PK Analysis SA-112 Nanjing
PharmaSUG2023paper·China·7 Statistics and Analytics
Pharmacodynamics Analysis using AUC as endpoint in Single Ascending Dose Study SA-134 Nanjing
PharmaSUG2023paper·China·7 Statistics and Analytics
Response evaluation criteria practice for skin cancer by RECIST 1.1, or modified World Health Organization (WHO) criteria or composite criteria SA-142 Nanjing
PharmaSUG2023paper·China·7 Statistics and Analytics
How to better understand mRECIST – novel refinements for evaluating HCC SA-154 Nanjing
PharmaSUG2023paper·China·7 Statistics and Analytics
Alignment between Estimand and Estimator with rbmi SA-161 Nanjing
PharmaSUG2023paper·China·7 Statistics and Analytics
Introduction of Matching Adjusted Indirect Comparison (MAIC) SA-182 Nanjing